Načítá se...
The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone
The field of pharmacogenomics originally emerged in the 1950s from observations that a few rare individuals had unexpected, severe reactions to drugs(1). As recently as just six years ago, prominent views on the subject had largely remained unchanged, with authors from the FDA citing the purpose of...
Uloženo v:
| Vydáno v: | Clin Pharmacol Ther |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4830348/ https://ncbi.nlm.nih.gov/pubmed/26756170 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cpt.333 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|